These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29226736)

  • 1. The effect of major adverse renal cardiovascular event (MARCE) incidence, procedure volume, and unit cost on the hospital savings resulting from contrast media use in inpatient angioplasty.
    Keuffel E; McCullough PA; Todoran TM; Brilakis ES; Palli SR; Ryan MP; Gunnarsson C
    J Med Econ; 2018 Apr; 21(4):356-364. PubMed ID: 29226736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iso-osmolar contrast media and adverse renal and cardiac events after percutaneous cardiovascular intervention.
    McCullough PA; David G; Todoran TM; Brilakis ES; Ryan MP; Gunnarsson C
    J Comp Eff Res; 2018 Apr; 7(4):331-341. PubMed ID: 29117715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major Adverse Renal and Cardiovascular Events following Intra-Arterial Contrast Media Administration in Hospitalized Patients with Comorbid Conditions.
    McCullough P; Ng CS; Ryan M; Baker ER; Mehta R
    Cardiorenal Med; 2021; 11(4):193-199. PubMed ID: 34433166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of iso-osmolar contrast media during endovascular revascularization is associated with a lower incidence of major adverse renal, cardiac, or limb events.
    Prasad A; Amin AP; Ryan MP; Gunnarsson C; Brilakis ES
    Catheter Cardiovasc Interv; 2022 Mar; 99(4):1335-1342. PubMed ID: 34766727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Iso-Osmolar vs Low-Osmolar Contrast Media With Major Adverse Renal or Cardiovascular Events in Patients at High Risk for Acute Kidney Injury Undergoing Endovascular Abdominal Aortic Aneurysm Repair.
    Amin AP; Prasad A; Ryan MP; Gunnarsson C; Brilakis ES
    J Invasive Cardiol; 2021 Aug; 33(8):E640-E646. PubMed ID: 34280892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate of major adverse renal or cardiac events with iohexol compared to other low osmolar contrast media during interventional cardiovascular procedures.
    McCullough PA; Todoran TM; Brilakis ES; Ryan MP; Gunnarsson C
    Catheter Cardiovasc Interv; 2019 Feb; 93(2):E90-E97. PubMed ID: 30280476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are iso-osmolar, as compared to low-osmolar, contrast media cost-effective in patients undergoing cardiac catheterization? An economic analysis.
    Hiremath S; Akbari A; Wells GA; Chow BJW
    Int Urol Nephrol; 2018 Aug; 50(8):1477-1482. PubMed ID: 29687326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic evaluation of intravenous iodinated contrast media in Italy.
    Iannazzo S; Vandekerckhove S; De Francesco M; Nayak A; Ronco C; Morana G; Valentino M
    Int J Technol Assess Health Care; 2014 Jan; 30(1):69-77. PubMed ID: 24485022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic impact of contrast-induced acute kidney injury associated with invasive cardiology: role of iso-osmolar contrast media in Germany, Italy, Poland, and Spain.
    De Francesco M; Ronco C; Wacinski PJ; Wessely R; Hernández F; Lamotte M
    J Med Econ; 2016; 19(2):158-68. PubMed ID: 26451530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High incidence of nephropathy in neurosurgical patients after intra-arterial administration of low-osmolar and iso-osmolar contrast media.
    Serafin Z; Karolkiewicz M; Gruszka M; Strózecki P; Lasek W; Odrowaz-Sypniewska G; Manitius J; Beuth W
    Acta Radiol; 2011 May; 52(4):422-9. PubMed ID: 21498279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of the risk of total cardiovascular events of isosmolar iodixanol compared with low-osmolar contrast media.
    Zhang BC; Wu Q; Wang C; Li DY; Wang ZR
    J Cardiol; 2014 Apr; 63(4):260-8. PubMed ID: 24397991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routine iso-osmolar contrast media use and acute kidney injury following percutaneous coronary intervention for ST elevation myocardial infarction.
    Premawardhana D; Sekar B; Ul-Haq MZ; Sheikh A; Gallagher S; Anderson R; Copt S; Ossei-Gerning N; Kinnaird T
    Minerva Cardioangiol; 2019 Oct; 67(5):380-391. PubMed ID: 31527583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iso-osmolar versus low-osmolar contrast media and outcomes after percutaneous coronary intervention: Insights from the VA CART Program.
    Jovin IS; Warsavage TJ; Plomondon ME; Grunwald GK; Waldo SW; Rao SV; Brilakis ES; Azzalini L
    Catheter Cardiovasc Interv; 2022 Jul; 100(1):85-93. PubMed ID: 35500170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative renal safety of iodixanol and low-osmolar contrast media in patients undergoing percutaneous coronary intervention. Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
    Reed MC; Moscucci M; Smith DE; Share D; LaLonde T; Mahmood SA; D'Haem C; McNamara R; Greenbaum A; Gurm HS
    J Invasive Cardiol; 2010 Oct; 22(10):467-72. PubMed ID: 20944185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
    Giustino G; Baber U; Mastoris I; Vlachojannis GJ; Yu J; Teirstein PS; Downey WE; Batchelor WB; Casterella PJ; Nikolsky E; Wong SC; Theodoropoulos KN; Dangas GD; Mehran R
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):703-9. PubMed ID: 26481591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Adverse Effects of Low-Osmolar Compared With Iso-Osmolar Contrast Media After Coronary Angiography.
    Wang YC; Tang A; Chang D; Lu CQ; Zhang SJ; Ju S
    Am J Cardiol; 2016 Oct; 118(7):985-90. PubMed ID: 27521223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effect of iso-osmolar versus low-osmolar contrast media on the incidence of contrast-induced acute kidney injury in diabetic patients: a systematic review and meta-analysis.
    Zhao F; Lei R; Yang SK; Luo M; Cheng W; Xiao YQ; Li XW; Guo J; Duan SB
    Cancer Imaging; 2019 Jun; 19(1):38. PubMed ID: 31215488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative tolerability of contrast media used for coronary interventions.
    Esplugas E; Cequier A; Gomez-Hospital JA; Del Blanco BG; Jara F
    Drug Saf; 2002; 25(15):1079-98. PubMed ID: 12452733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of iso- versus low-osmolality contrast media in outpatients with high risk of contrast medium-induced nephropathy.
    Chicaíza-Becerra LA; García-Molina M; Gamboa Ó
    Biomedica; 2012 Jun; 32(2):182-8. PubMed ID: 23242291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
    Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.